Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.

1. Single doses (10, 30 and 100 mg) of atipamezole (MPV-1248), a new potent and selective imidazole-type alpha 2-adrenoceptor antagonist, and saline placebo were administered as 20 min intravenous infusions to six healthy male volunteers in a randomized double-blind, cross-over phase I study. Later,...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Karhuvaara, S, Kallio, A, Scheinin, M, Anttila, M, Salonen, J S, Scheinin, H
Format: Artigo
Jezik:Inglês
Izdano: 1990
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1368280/
https://ncbi.nlm.nih.gov/pubmed/1975199
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki